TrialDiabetes, obesity & metabolism2015

One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial.

What the trial testedas reported · 2015

No range given

−2.80kg

As reported

difference −2.80 kg, no interval

the abstract, start to end

… weight (estimated treatment difference, -2.80 kg, p < 0.0001) and a 37% lower …

← favours treatmentfavours comparator →

could be chance

No interval given · direction only, strength unknown

Body weight & composition

−2.80

InsulinBody weight & composition

1 / 3

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

this paperpooled ittrialcites it